Dopamine beta-hydroxylase
| GO Term |
|---|
| leukocyte mediated immunity |
| memory |
| locomotory behavior |
| glucose homeostasis |
| leukocyte migration |
| response to amphetamine |
| homoiothermy |
| response to pain |
| vasoconstriction |
| blood vessel remodeling |
| GO Term |
|---|
| dopamine beta-monooxygenase activity |
| copper ion binding |
| L-ascorbic acid binding |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 68 | N-linked (GlcNAc...) asparagine |
|
||
| 188 | N-linked (GlcNAc...) asparagine |
|
||
| 208 |
|
|
||
| 476 | N-linked (GlcNAc...) asparagine | |||
| 570 | N-linked (GlcNAc...) asparagine |
| Pathway Name | Organism |
|---|---|
| Catecholamine biosynthesis | Mus musculus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0090145 | dopamine beta-hydroxylase deficiency |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025